EUVIMEDEUVIMED entdecken
Crossref

Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity

Jiatong Li iD, Ao Gu, Meng-Yao Li iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202401469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Jiatong Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200…. Hauptthemen laut MEDLINE: Alkenes, Antineoplastic Agents, Cell Proliferation, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatobililary cancers are fatal solid tumors that pose a significant threat to human life. It is imperative to investigate novel small molecule active compounds for controlling these cancers. Heterocyclic compounds (e. g. gemcitabine) and multi‐substituted alkenes (e. g. resveratrol) are commonly applied in tumor treatment. Researchers have proposed that the synthesis of new trisubstituted alkenes containing heteroaromatic rings by combining these two scaffolds may be a fresh strategy to develop new active molecules. In this study, we utilized alkenyl bromide and heteroaryl boronic acid as substrates, employing Suzuki coupling to generate a series of triarylethylenes featuring nitrogen, oxygen, and sulfur atoms. Through in vitro experiments, the results indicated that some compounds exhibited remarkable anti‐tumor efficacy (e. g. IC50 [ 3be , GBC‐SD] =0.13 μM and IC50 [ 3be , PANC‐1] =0.27 μM). The results further demonstrated that the antitumor efficacy of these compounds was dependent on the heteroatom, π‐system, skeleton‐bonding site, and substituent type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkenesAntineoplastic AgentsCell ProliferationDrug Screening Assays, AntitumorHumansCell Line, TumorDose-Response Relationship, DrugMolecular StructureStructure-Activity RelationshipHeterocyclic Compounds

Stichwörter der Autor:innen

Anti-tumor efficacyHeterocyclic derivativesPancreatobililary cancersTrisubstituted alkenes

Substanzen

AlkenesAntineoplastic AgentsHeterocyclic Compounds

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200032, Shanghai, China.
  • Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 200127, Shanghai, China.

ORCID-Profile: Jiatong Li, Meng-Yao Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Gu, A., & Li, M. Y. (2024). Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401469

Vancouver

Li J, Gu A, Li MY. Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401469

BibTeX
@article{Li2024,
  author = {Li, Jiatong and Gu, Ao and Li, Meng-Yao},
  title = {Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐Tumor Activity},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202401469}
}
Kostenlos starten →